Ecuador is set to legalise CBD for medical use. This and other updates from the US, Canada, Mexico, Thailand, Zambia and Europe
Restricted content. Do you want to read more?
The data you have tried to access is restricted to our subscribers, or may not be available in your subscription package. CBD-Intel regulatory alerts offer a consolidated weekly list of alerts, allowing tracking of policy change and development of key legislation.
You can find available reports for purchase in our
online store. Reports not listed in the store are available under request. If you are interested in a subscription, get in contact to discuss our subscription plans or to upgrade your current access.
CBD-Intel provides premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sectors, with a focus on non-US markets.
We provide our clients with the tools to navigate this fast-moving sector, tailor their business strategy, optimise resources and make informed decisions.